XML 75 R52.htm IDEA: XBRL DOCUMENT v3.25.0.1
Share-based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Compensation Cost For Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan
We recognized the following stock compensation expense:
Year Ended December 31,
(in Millions)202420232022
Stock option expense, net of taxes of $1.6 in 2024, $1.5 in 2023 and $1.3 in 2022 (1)
$6.1 $5.9 $4.9 
Restricted stock expense, net of taxes of $2.6 in 2024, $2.4 in 2023 and $2.3 in 2022 (2)
9.8 9.0 8.5 
Performance based expense, net of taxes of $0.8 in 2024, $1.5 in 2023 and $1.5 in 2022
2.9 5.6 5.7 
Total stock compensation expense, net of taxes of $5.0 in 2024, $5.4 in 2023 and $5.1 in 2022 (3)
$18.8 $20.5 $19.1 
___________________________
(1)We applied an estimated forfeiture rate of 4.0% per stock option grant in the calculation of the expense.
(2)We applied an estimated forfeiture rate of 2.0% of outstanding restricted stock grants in the calculation of the expense.
(3)This expense is classified as "Selling, general and administrative expenses" in our consolidated statements of income (loss).
Schedule of Black Scholes Valuation Assumptions for Stock Option Grants
Black Scholes valuation assumptions for stock option grants: 
202420232022
Expected dividend yield4.43 %1.80 %1.85 %
Expected volatility34.08 %31.99 %33.18 %
Expected life (in years)6.46.56.5
Risk-free interest rate4.26 %4.00 %1.91 %
Schedule of Stock Option Activity
The following summary shows stock option activity for employees under the Plan for the three years ended December 31, 2024:
(Shares in Thousands)Number of Options Granted But Not ExercisedWeighted-Average Remaining Contractual LifeWeighted-Average Exercise Price Per ShareAggregate Intrinsic Value (in Millions)
December 31, 2021 (605 shares exercisable and 622 shares expected to vest or be exercised)
1,254 6.2 years$78.95 $38.8 
Granted248 114.90 
Exercised(166)62.74 9.6 
Forfeited(31)102.32 
December 31, 2022 (672 shares exercisable and 607 shares expected to vest or be exercised)
1,305 6.1 years$87.35 $48.9 
Granted222 128.92 
Exercised(88)62.42 4.6 
Forfeited(43)114.15 
December 31, 2023 (824 shares exercisable and 551 shares expected to vest or be exercised)
1,396 5.6 years$94.73 $1.6 
Granted1,181 52.50 
Exercised(5)36.85 — 
Forfeited(101)79.32 
December 31, 2024 (1,299 shares exercisable and 1,098 shares expected to vest or be exercised)
2,471 6.3 years$75.28 $0.5 
Schedule of Restricted Award Activity
The following table shows our employee restricted award activity for the three years ended December 31, 2024:
Restricted EquityPerformance Based Equity
(Number of Awards in Thousands)
Number of
awards
Weighted-Average Grant Date Fair Value Per ShareNumber of
awards
Weighted-Average Grant Date Fair Value Per Share
Nonvested at December 31, 2021270 $89.56 195 $96.18 
Granted103 114.50 45 140.32 
Vested(102)77.80 (102)83.74 
Forfeited(14)102.64 (2)125.60 
Nonvested at December 31, 2022257 $104.54 136 $120.47 
Granted118 110.71 81 137.18 
Vested(78)93.32(58)108.57
Forfeited(15)114.88 (6)136.25 
Nonvested at December 31, 2023282 $109.67 153 $131.60 
Granted297 53.41 105 50.01 
Vested(99)100.69 (15)100.63 
Forfeited(22)86.19 (7)62.06 
Nonvested at December 31, 2024458 $76.34 236 $85.65